Court May Ask Roche To Pay Amgen 22.5 Percent Mircera Marketing Royalty
This article was originally published in The Pink Sheet Daily
Executive Summary
Preliminary injunction bars launch of Roche’s Mircera; suggests terms to avoid a permanent injunction.